White to Lead Integration of Canabo Medical
Clinics and GrowWise Health Post-closing of Emblem
AcquisitionPreviously the COO of Canada’s Largest Multidisciplinary
Clinic Network
Aleafia Health Inc. (TSXV: ALEF, OTC: ALEAF, FRA: ARAH)
(“
Aleafia Health” or the
“
Company”), has named private healthcare executive
Keith White as the Company’s new President of Clinic Operations.
Most recently, White was The Oshawa Clinic’s
(“
Oshawa”) Chief Operating Officer. Oshawa, the
largest of its kind in Canada, is a Greater Toronto Area
multidisciplinary medical clinic network with over 500,000 unique
patients. White also serves as the Chairman of the Lakeridge Health
Foundation, a healthcare not-for-profit.
During his Oshawa tenure, White facilitated its exponential
growth, including expanding from 45 physicians to over 130.
Additionally, White streamlined patient care by scaling the
institution of a new Electronic Medical Record (EMR) system that
enabled physicians to access digital patient records while working
within the public hospital system.
In his new leadership role, White will integrate Aleafia
Health’s wholly owned Canabo Medical Clinics and Emblem’s
(“Emblem”)(TSXV: EMC, OTCQX: EMMBF) GrowWise
Health, following the closing of the Company’s previously announced
Emblem acquisition.
White’s hiring will accelerate Aleafia Health’s global
initiative to build an integrated, scalable cannabis consumer
experience, leveraging the Company’s in-house, executive leadership
background at multi-billion-dollar eCommerce and IT companies. Over
the next three months, the Company will launch unique, highly
differentiated cannabis education and ecommerce platforms,
utilizing its proprietary 10-million-point medical cannabis
dataset, and Emblem’s robust product portfolio of high-margin
capsules, oils and sprays.
“Aleafia Health will enable patients to navigate seamlessly
through cannabis education, illness specific questionnaires,
medical cannabis script product purchasing, order subscription
management and treatment/titration monitoring within an integrated,
globally scalable platform,” said Aleafia Health CEO Geoffrey
Benic. “White will, in conjunction with our marketing and
technology team, oversee Aleafia Health applying the best practices
of global ecommerce and healthcare companies for the benefit of our
patients and shareholders.”
Dr. Gary Goodyear, previously President, Clinic Operations will
continue to serve on Aleafia Health’s board of directors.
“I thank Gary Goodyear for his outstanding service to Aleafia
Health. Gary has expanded our research and development division,
while modernizing our clinics with the introduction of Nurse
Practitioners and telemedicine,” added Benic.
“I am thrilled to join Aleafia Health as we build a globally
scalable, integrated cannabis health and wellness experience where
patient and customer needs come first,” said White. “Much like the
global cannabis industry, scaling Canada’s largest
multidisciplinary clinic network is only possible with modern,
innovative tech solutions. These will be needed to manage the needs
of patients and medical professionals while ensuring compliance
with an increasingly complex web of multi-jurisdiction regulations.
Aleafia Health’s experienced team will do just that.”
Additionally, Aleafia Health has entered into a Public Markets
Investor advisory agreement (the “Agreement”),
with Emerging Growth, LLC (“Emerging Growth”),
owners of CFN Media subject to TSX Venture Exchange approval.
Emerging Growth provides the Company with investor relations
services including capital markets awareness services, and will be
paid a sum of $30,000, paid in three monthly installments. The
agreement expires on March 19, 2019. The Company has no prior
relationship with Emerging Growth, and to the Company’s knowledge,
Emerging Growth does not own or control any securities of the
Company.
LEARN MORE: https://www.AleafiaHealth.com/Invest
For Investor & Media Relations, please
contact:
Nicholas Bergamini, VP, Public
Affairs416-860-5665IR@AleafiaInc.com
About Aleafia Health:
Aleafia Heath, a vertically integrated, global cannabis company,
operates major medical clinic, cannabis cultivation and R&D
divisions. A federally licensed producer and vendor of cannabis,
the company has a planned and fully-funded annual production
capacity of 98,000 kg of dried cannabis flower.
The Company operates medical cannabis clinics staffed by
physicians and nurse practitioners, with over 50,000 patients. The
company is highly differentiated, maintaining the largest medical
cannabis dataset in the world, which it used to develop unique,
proprietary cannabis products and treatment methods.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the Exchange)
accepts responsibility for the adequacy or accuracy of this
release.
FORWARD LOOKING INFORMATION
This press release contains forward-looking statements and
information that are based on the beliefs of management and reflect
the Company's current expectations. When used in this press
release, the words "estimate", "project", "belief", "anticipate",
"intend", "expect", "plan", "predict", "may" or "should" and the
negative of these words or such variations thereon or comparable
terminology are intended to identify forward-looking statements and
information.
The forward-looking statements and information in this press
release includes information relating to the implementation of
Aleafia Health's business plan. Such statements and information
reflect the current view of the Company with respect to risks and
uncertainties that may cause actual results to differ materially
from those contemplated in those forward-looking statements and
information.
By their nature, forward-looking statements involve known and
unknown risks, uncertainties and other factors which may cause our
actual results, performance or achievements, or other future
events, to be materially different from any future results,
performance or achievements expressed or implied by such
forward-looking statements. Such factors include, among others, the
following risks: risks associated with the implementation of
Aleafia Health's business plan and matters relating thereto, risks
associated with the cannabis industry, competition, regulatory
change, the need for additional financing, reliance on key
personnel, the potential for conflicts of interest among certain
officers or directors, and the volatility of the Company's common
share price and volume. Forward-looking statements are made based
on management's beliefs, estimates and opinions on the date that
statements are made, and the Company undertakes no obligation to
update forward-looking statements if these beliefs, estimates and
opinions or other circumstances should change. Investors are
cautioned against attributing undue certainty to forward-looking
statements.
A photo accompanying this announcement is available at
http://www.globenewswire.com/NewsRoom/AttachmentNg/786b27ab-c36d-49b2-9334-bc549780efab
Emblem Corp (TSXV:EMC)
Historical Stock Chart
From Aug 2024 to Sep 2024
Emblem Corp (TSXV:EMC)
Historical Stock Chart
From Sep 2023 to Sep 2024